Web Sites by Topic


 Internal Web Sites

   Biotechnology Web Sites
Contact Mary Bryant, RiskWorld staff, e-mail bryant@tec-com.com.
Access Excellence
Access Excellence is a national educational program that provides high school biology and life science teachers access to their colleagues, scientists, and critical sources of new scientific information via the World Wide Web. A brief history of biotech discoveries which continue to influence the field today, called Biotech Chronicles, is included at this site. Essays on genetics and DNA research, profiles of some of the influential individuals who have helped build the biotechnology industry, and an integrated series of time lines which provide an overview of biotechnology from a historical perspective are included in the Biotech Chronicles. (Posted September 2000.)
Agricultural Biotechnology
The United States Department of Agriculture (USDA) is one of three Federal Agencies, along with the Environmental Protection Agency (EPA) and the U.S. Food and Drug Administration (FDA), primarily responsible for regulating biotechnology in the United States. Products are regulated according to their intended use, with some products being regulated under more than one agency. (Posted October 2000.)
AGROGENE is a leader in plant biotechnology. The company's biotechnological expertise includes plant and animal breeding; fingerprinting and protection; genetic resources; industrial uses of plants; genetics; traceability and quality control; and GMO detection and quantification. (Posted October 2000.)

APSnet - Plant Pathology On-Line

The international scientific organization American Phytopathological Society has been devoted to the study of plant diseases and their control since its founding in 1908. The society's members promote knowledge of plant diseases and their control through publications, meetings, symposia, workshops and special activities, as well as this web site. (Posted October 1999.)

Aurora Biosciences Corporation
Aurora Biosciences Corporation designs, develops and commercializes proprietary drug discovery systems and technologies to accelerate and enhance discovery of new medicines by the pharmaceutical and biopharmaceutical industries. The Company is developing a proprietary biology and high technology platform comprised of a portfolio of proprietary functional genomics technologies, and a highly automated ultra-high throughput screening system, known as the Company's UHTSS Platform.  (Posted September 2000.)
Australian Biotechnology Association
The Australian Biotechnology Association is a national body of companies and individuals dedicated to the development and prosperity of the Australian biotechnology industry. It is the peak body for the Australian Biotechnology industry, and provides a ‘platform’ which brings together all the relevant players involved in the Australian biosciences community. Its mission is to facilitate the commercialisation of Australian bioscience in the international marketplace. This website provides information about the ABA, coming biotech events, and on-line access to a directory of Australian biotech companies and organisations, the ABA’s journal "Australasian Biotechnology" and the ABA series of educational leaflets. (Posted September 2000.)
Biotechnology Abreviation and Acronym Uncovering Service (BioABACUS) is a searchable database of abbreviations and acronyms in Biotechnology that contains terms in such categories as: Biochemistry, Cell Biology, Computers and Internet, Diseases, Grants, Journals, Laboratories, Medicine, Molecular Biology/Genetics, Neuroscience, Other Organizations, Professional Societies and US Government. The data provided include the name of the term, its meaning, the category in which it is mostly used and, when available, a link in which additional information for the term can be found. (Posted September 2000.)
BIOCODE S.A. is a biotechnology company established in Liège, a city near Brussels, the capital of the European Economic Community. It specializes in the research, development, production and distribution of in vitro diagnostic kits (IVD). The company produces poly- and monoclonal antibodies in house and purifies proteins and peptides, runs immuno- and radioligand receptor assays as well as enzyme immuno- and DNA probe assays. BIOCODE’s policy is to systematically upgrade and diversify its technologies and products in parallel with the progress of biotechnology and medicine. (Posted October 2000.)
BIOCOM/san diego
BIOCOM/san diego is the regional association for biotechnology, medical device and bio-agriculture companies in San Diego County. It includes a significant service company sector, including finance, legal, architecture, marketing, insurance and other companies specializing in business with the life science industry. The company is actively engaged in ensuring that the life science industry remains a strong and growing part of the region's economy. BIOCOM proactively addresses significant business and legislative issues, educates the general public, and develops programs to help these companies operate efficiently and economically. (Posted October 2000.)
Biofind is the Internet's "one-stop-shop" for world wide Biotechnology industry information and news. (Posted October 2000.)
BioInformatics Services (BIS)
BIS is a biotechnology firm specializing in applying the power of computational biology to build solutions to complex biological and data analysis problems faced by scientists in public and private research institutes, biotechnology companies, and universities. (Posted October 2000.)
Biology and Biotechnology Research Program at the Lawrence Livermore National Laboratory
The Biology and Biotechnology Research Program is focused on three strategic thrust areas: genomics, disease susceptibility and prevention, bioengineering research. These thrust areas provide a set of core compentencies and a foundation for our laboratory-wide strategic plan in the biosciences. (Posted October 2000.)
BioMetics, Inc. 
BioMetics, Inc. provides engineering, design, validation, cGMP consulting and project management services for biopharmaceutical and environmental technology companies. The company delivers the highest quality of services, adding value to each project through innovative approaches to design and cost containment. (Posted October 2000.)
Bio Online
Bio Online is a comprehensive site for biotechnology-related information and services. The site contains current news, featured articles, events, industry reports and analyses, press releases, product information, and much more. Bio Online exists to create a distributed on-line community of scientists, professionals, businesses and organizations supporting the life sciences for the purpose of facilitating communications and disseminating information within that community. Opening channels of information can only benefit those who strive to contribute to these endeavors. (Posted September 2000.)
A global hubsite for the life sciences, including current news, industry events, resources, search tools, and much more, to help foster a worldwide community of shared interests within the biotech industry. (Posted September 2000.) 
BioTech's Biotechnology Dictionary
A searchable online dictionary of biology, chemistry and biotechnology terms. This free resource is still very much under construction. Currently, most of the 8300+ terms deal with biochemistry, biotechnology, botany, cell biology and genetics. There are also some terms relating to ecology, limnology, pharmacology, toxicology and medicine. Don't expect to find common or exotic animals here; there are far too many species to cover even a fraction in a resource like this. However, medically- and biotechnologically-relevant organisms such as bacteria, worms, fungi, and some plants are included. Looking for a chemical acronym? Try searching BioTech's Chemical Acronyms Database. (Posted September 2000.)
BIOTECanada is a national organization dedicated to promoting a better understanding of biotechnology and the many ways it contributes to improving the quality of life of all Canadians. BIOTECanada represents Canadian health care, agricultural, food, research and other organizations that are involved in biotechnology. (Posted September 2000.)
Biotech Medical Management Association (BMMA)
BMMA, a non-profit professional organization, establishes a forum for the open exchange of ideas and information between the pharmaceutical manufacturers and the health plan/payor community. The views of clinical provider, employer, consumer, and government representative members provide a balanced view on utilization management and therapeutic care standards. The goal of BMMA is to encourage active membership to impact and guide the future development of medical policy regarding new and evolving pharmaceutical products. With over 50% of the national population impacted by managed care and managed drug benefits, payors and providers are more actively involved in the approval and reimbursement of current and newly developed products.  (Posted September 2000.)
Bio-Technical Resources 
Bio-Technical Resources provides innovative solutions for the development of biotechnology products and processes through contract services in research and development, bioprocess scale-up, pilot scale manufacturing, technology and economic assessments. (Posted October 2000.)
Biotechnology and Biological Sciences Research Council (BBSRC) 
The BBSRC is the leading funding agency for academic research and training in the biosciences at universities and institutes throughout the UK. The research that funded aims to improve the understanding of living organisms and biological systems in seven major areas: agri-food, animal sciences, biochemistry and cell biology, biomolecular sciences, engineering and biological systems, genes and developmental biology, and plant and microbial sciences. (Posted October 2000.)
Biotechnology Group of Danish Institute of Agricultural Sciences
Biotechnology Group of Danish Institute of Agricultural Sciences, DIAS, is a small research team engaged in plant breeding related research. Promoting the use of transgenic crop plants in agriculture is at the core of all research activities of the group. All projects comprise a mix of applied and fundamental science, and the Group is thus an important link between applied oriented DIAS and the Danish universities. (Posted October 2000.)

Biotechnology Industry Organization

This international trade association, also known as BIO, represents companies, academic institutions, and state biotechnology centers. Its members are involved in the research and development of health care, agricultural, industrial, and environmental biotechnology products. BIO's web resources include a guide to biotechnology for editors and reporters and information about biotech issues and policies regarding food and agriculture, bioethics, and biotech drugs. (Posted May 2000.)

Biotechnology Program at UC Davis
UC Davis has long enjoyed a reputation as one of the world’s leading institutions for research in biological sciences. UC Davis houses leading departments in each of the major areas where biotechnology has a significant impact: agriculture covering plant, animal, microbial science, entomology and sustainability; medicine and veterinary medicine including therapeutics, diagnostics and pathology; food science; bioprocess technology and environmental science. Research in molecular and cellular biology and biochemistry has led to the development of new research approaches and the new tools of biotechnology. UC Davis views these recent research results as part of a progressive cycle, with technology contributing to the advancement of research goals and biological research contributing, in turn, to the advancement of technology(Posted September 2000.)
BioTime, Inc.
BioTime, Inc. is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery. (Posted October 2000.)
The principle goal of BioValley is the promotion of greater cooperation between companies involved in the biotechnological and biomedical sectors and the internationally respected scientific institutions associated with universities in the BioValley area, most of which have already formed close links between themselves. The intention is to address not only the many pharmaceutical concerns already present in the BioValley area, but also to involve the region's numerous smaller enterprises and suppliers. This calls for the creation of a network strongly committed to technology transfer. (Posted October 2000.)
BIRD Engineering
Biotechnology Integrated Research, Development & Engineering (BIRD Engineering)  specialises in contract research and engineering in the areas of the fermentation technology and downstream processing. BIRD Engineering was founded by the combined initiative of researchers working in the field of bioprocess engineering, industrial microbiology and biochemistry at Delft University of Technology and Applikon Dependable Instruments, manufacturer of fermentation equipment and analytical instruments. BIRD was originally set up to bridge the gap between research at universities and industrial activities in biotechnology. The company not only performs the necessary research but can also the development and engineering studies with respect to industrial biotechnological applications. In this way, BIRD comes up with solutions for your problem that is not just an academic one but has also a practical value. The main focuses are on those application areas which require a combined know-how of bioprocess technology, microbiology, biochemistry and genetics. In this central position BIRD is able to assist from the selection of micro-organisms to scale-up of production processes. (Posted October 2000.)
Boston Biomedica, Inc.
Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral Hepatitis. Boston Biomedica is also pursuing research and development programs in other areas, including Pressure Cycling Technology (PCT), a new technology which may allow more precise control chemical of reactions through the use of pressure. (Posted October 2000.)
Boston Life Sciences, Inc.
Boston Life Sciences, Inc., is a development stage biotechnology company engaged in the research and development of novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. The Company currently has 11 technologies in its product portfolio, the majority of which were invented or discovered by researchers working at Harvard and its affiliates and have been licensed to the Company. (Posted October 2000.)
California Healthcare Institute
The mission of California Healthcare Institute is to (1) research, develop, and advocate policies and actions that promote biomedical science, biotechnology, pharmaceutical and medical device innovation in California; (2) create a favorable environment for the State's biomedical and health care technology community to discover, produce, and deliver products that benefit society; (3)provide a forum to identify, analyze, and develop positions on public policy issues that affect California's biomedical and health care technology interest; (4) conduct research as a basis for advocating responsible state and federal policies; (5) communicate to public officials, providers, patients, and the general public the value of the State's health care technology community for the health and economic well-being of our nation's citizens and the economic growth of California; and (6) identify and communicate the value of the products of health care technology with regard to cost, benefit, and patients' quality of life. (Posted October 2000.)
Cambridge Healthtech Institute (CHI) 
CHI services the biotechnical and biomedical markets by acting as an information resource in an ever-changing environment. Through the organization of scientific conferences and publication of market reports, CHI offers a one-stop resource for learning about the latest technological developments in such areas as genomics, drug discovery and development, lab instrumentation, and blood products. CHI holds over 50 U.S. and international events each year, and currently offer over 12 market reports in its new Genomic Pathways Report Series. CHI events facilitate interaction with key decision makers from leading pharmaceutical and biotech organizations. This format offers companies who sponsor or exhibit at a CHI event direct access to individuals who are interested in their products and services. (Posted September 2000.)
Capralogics Inc.
Capralogics provides custom antibody services to the research community and is a manufacturer of polyclonal antibodies against cell membrane receptors, nuclear components, apoptosis factors, neuropeptides, oncoproteins, signaling intermediates, transcription factors and proteins involved in infectious diseases. The company offers a complete service package ranging from protocol and peptide development through purification services. (Posted October 2000.)
Cascade Biologics Inc.
Cascade Biologics is a supplier of cell culture and molecular biology products. The scientists at Cascade Biologics are experts in the isolation and propagation of numerous cell types from different tissues, and in the development of specialized cell culture media for the growth of these cells. (Posted October 2000.)
CEDRA Corporation
CEDRA Corporation is a provider of excellence in biotechnical services for the pharmaceutical industry and federal government. In addition to analytical chemistry services, CEDRA also offers toxicology/pharmacology, metabolic, synthetic chemistry, and pharmacokinetic/statistical services. (Posted October 2000.)
Cell Genesys Inc.
Cell Genesys is engaged primarily in the development and commercialization of gene therapies to treat major, life-threatening diseases, including cancer and AIDS. Cell Genesys currently has two gene therapy programs, the clinical programs and the pre-clinical programs. The clinical programs include GVAX(tm) cancer vaccines in Phase I/II studies to treat specific types of cancer, such as lung and prostate cancers, and T cell gene therapy for AIDS, which is undergoing Phase II testing. (Posted October 2000.)
Cell Trends Inc.
Cell Trends Inc. is a biotechnology firm that offers technical and research project work to scientists of virtually every level of sophistication: industry, government agencies, medical schools, colleges, and universities. Cell Trends offers a wide range of cell based laboratory services, utilizing a diverse selection of mammalian and insect cell lines. Features include baculovirus gene expression, DNA recombinant technology, soluble and membrane bound protein production (using hollow fiber bioreactors, roller bottles, or spinner flasks), gene cloning, transformant selection, electrophoresis, PCR, ELISA, and selection of immortalized cell lines.  (Posted October 2000.)
Center for Advanced Biotechnology and Medicine (CABM)
CABM was established in response to a recommendation in the report of the Governor's Commission on Science and Technology that New Jersey should create and maintain a world-class center in biotechnology. Launched in 1985, CABM now encompasses the Core Facility, conducting basic research in the areas of structural biology, molecular genetics, and cell and developmental biology; and educational Programs, including lectures, seminars, symposia, short courses, fellowships, and visiting scientist programs. (Posted September 2000.)
Center for Advanced Research in Biotechnology (CARB)
CARB, located at the University of Maryland, was designed to meet the specific needs of the biotechnology community in the field of protein structure, function, and design. Scientists from the Biotechnology Division of the Chemical Science and Technology Laboratory of NIST and the University of Maryland have come together to conduct research programs in structural and physical biochemistry and molecular biology. CARB, with sophisticated state-of-the-art instrumentation, provides an exceptional environment for training graduate students and postdoctoral fellows in fields critical to the future of biotechnology. CARB offers a Visiting Scientists Program that allows researchers from industrial, academic, and governmental laboratories to work at the facility for extended periods. (Posted September 2000.)
Center for Biotechnology at Oak Ridge National Laboratory
Biotechnology is an integrating science that emphasizes the development and application of biological approaches, or the use of engineering and computational capabilities, to meet national needs in health and environmental protection, biomedical applications, environmental remediation, pollution abatement, and energy production. ORNL is uniquely positioned in this emerging field owing to its diversity of interactive disciplinary foundations (e.g., biology, biochemistry, molecular biology, computational sciences, chemistry, ecology, bioengineering, and biophysics) and its core competency in biological and environmental science and technology. The ORNL Center for Biotechnology provides a coordinated focus for this biotechnology program, integrating activities across 14 ORNL divisions and forming partnerships with other institutions, both public and private, throughout the world. (Posted September 2000.)
ChemGen is a privately held biotechnology company specializing in developing products through the use of microbial fermentation technology. The company's focus has been on the production of enzymes for patented applications and on chemicals, including pharmaceutical intermediates, using unique production processes. (Posted October 2000.)
ChemGenes Corporation
ChemGenes Corporation, a biotechnology company engaged in the field of DNA/RNA synthesis. ChemGenes holds a number of patents in the field of standard, modified, as well as backbone modified DNA/RNA synthesis products. (Posted October 2000.)
Cleveland Biotech Ltd.
Cleveland Biotech grows and acclimatises naturally occurring bacteria to create products for the degradation of organic wastes, including fats, oil and greases, cellulose, petroleum hydrocarbons, and chlorinated organics. Products are also available for the degradation of inorganic pollutants such as ammonia and nitrite. (Posted October 2000.)
Collateral Therapeutics
Collateral Therapeutics is focused on the discovery, development and commercialization of non-surgical gene therapy products for the treatment of cardiovascular diseases, including coronary artery disease, peripheral vascular disease, congestive heart failure and heart attack. The Company's non-surgical gene therapy product candidates include GENERX, GENEVX, GENVASCOR, GENECOR, CORGENIC, and MYOCOR. These non-surgical gene therapy products use technology, which includes methods of gene therapy, therapeutic genes, and gene delivery vectors. (Posted October 2000.)
Commonwealth Biotechnologies, Inc.
Commonwealth Biotechnologies provide sophisticated research and development support services on a contract basis to the biotechnology industry. The Company's customers consist of private companies, academic institutions and government agencies, all of which use biological processes to develop products for healthcare, agricultural and other purposes. The Company's revenues are derived principally from providing macromolecular synthetic and analytical services to researchers in the biotechnology industry or to researchers who are engaged in life sciences research in government or academic labs throughout the world. (Posted October 2000.)
Compugen is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery, therapeutic and diagnostic. Compugen provides innovative products and services to pharmaceutical, biotechnology and other life science organizations through corporate solutions and to individual life scientists. In addition, the company is commercializing the genes and proteins that are discovered through the company's drug discovery division. (Posted October 2000.)
Conversations about Plant Biotechnology
Monsanto Company hosts this website that offers video discussions from around the world with farmers and families who grow GM (genetically modified) crops and experts who research and study the benefits of agricultural biotechnology. (Posted July 2008.)
Corixa Corporation
Corixa Corporation is a research and development-based biotechnology company committed to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. The Company is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate proprietary vaccine components (antigens, adjuvants or antigen delivery technology) on a standalone, "Powered by Corixa" basis. (Posted October 2000.)
Council for Biotechnology Information
Leading biotechnology companies have founded Council for Biotechnology Information to create a public dialogue and to share information about biotechnology that is based on objective scientific research, independent expert opinion, and peer-reviewed published reports. The web site is also available in the French language. (Posted May 2000.)
Covance Inc.
Covance's biotechnology services include capabilities in cGMP manufacture of monoclonal antibodies, growth factors, cytokines, and other recombinant products for clinical trials and commercial use. The company offers a comprehensive range of experience developing biopharmaceutical production processes leading to optimal expression, purification, formulation, and testing of recombinant products. Equally important, Covance can effectively transfer established manufacturing processes into large-scale cGMP manufacturing areas and provide a reliable supply of the highest quality recombinant product. (Posted October 2000.)
CSL Limited
CSL Limited is an Australian public company specialising in the development, manufacture and marketing of biologically based health care products which benefit the community. Products include human and veterinary pharmaceuticals (notably vaccines) and products derived from human plasma, diagnostics, and cell culture reagents. CSL is firmly committed to research and development, quality assurance and the development of international product and marketing alliances. (Posted October 2000.)
CuraGen Corporation
CuraGen Corporation is an integrated, genomics-based drug discovery and development company that is revolutionizing the Life Sciences industry by merging biology with information technology. CuraGen has created an integrated suite of genomics technologies to better understand the role of genes in improving human health, animal health and agricultural vitality. This technology is being applied to augment the discovery and development efforts of the Company's collaborators, while simultaneously advancing the development of CuraGen's internal pipeline of protein therapeutics and antibody drugs for the treatment of complex diseases. (Posted October 2000.)
Dyadic International Inc.
Dyadic is a leader in the development and production of industrial enzymes and speciality chemicals, holding US and International patents. Currently the company's non-GMO products are used in the textile, food, starch and animal feed industries. An area targeted for future development is the pulp and paper industry. (Posted October 2000.)
Dynal Biotech
Dynal Biotech, a company in Oslo, Norway, developed Dynabeads, which are magnetic beads for efficient and quick separation of cells, bacteria, proteins, subcellular compartments, mRNA and DNA. This development has revolutionised the isolation and separation of many biological materials. For instance, the attachment of target-specific antibodies to the surface of the beads allows capture and isolation of intact cells directly from a complex suspension, such as blood. This is all accomplished under the influence of a simple magnetic field without the need of column techniques or centrifugation. Dynabeads have been applied to three major scientific areas: immunology, molecular biology, and microbiology. Dynal Biotech is now taking involvement in cancer research areas, such as the early detection of minimal residual cancer. In addition, the company continues to enhance its competence in its core technology; particle structure and surface chemistry, affinity ligands and immobilisation strategies combined with the on-going development of dedicated products as a solution provider in the biological and biomedical sciences.  (Posted October 2000, updated January 2001.)
Enchira Biotechnology Corporation
Enchira Biotechnology is a leading-edge biotechnology company incorporating genetic recombination and high throughput screening in an integrated, directed evolution technology platform. This proprietary platform technology can be used to generate libraries of novel genes for the creation of improved gene-based products for a broad range of applications, such as protein-based pharmaceuticals, agricultural crop enhancement and protection products, and industrial enzymes for manufacture of specialty chemicals, fine chemicals and pharmaceutical intermediates. The ability to generate novel proteins with enhanced or altered properties has stimulated interest in all areas of biotechnology, medicine, and the chemical sciences.  (Posted October 2000.)
Enviro Research Pty Ltd 
Enviro Research has been engaged in microalgal culture research for a number of years. The company has developed the world's first and only closed photobioreactor which can be scaled up to any volume. The Envirocell offers all the control, hygiene, efficiency and reliability of laboratory based culture systems at industrial volumes. The Envirocell is currently the best microalgal culture system in the world for the aquaculture industry, fine chemicals/pharmaceuticals companies, health food/nutraceuticals industry, and wastewater nutrients/toxins removal industry. (Posted October 2000.)
Epimmune Inc. 
Epimmune develops therapeutic products for treatment of immunological diseases. The company's core business is the development of vaccines to treat and prevent infectious diseases and cancer. Epimmune's business also includes a therapeutic anti-inflammatory program based on cell adhesion inhibitors and its Glytec business unit, encompassing proprietary manufacturing technology for the enzymatic synthesis of bioactive complex carbohydrates. (Posted October 2000.)
European Federation of Biotechnology
The European Federation of Biotechnology is a voluntary association of European non-profit-making scientific and technical societies active in the field of biotechnology. The aim of the association is to enhance cooperation between these societies in order to promote R&D in the multidisciplinary field of biotechnology and to support its scientific, economic and applied technical development in a socially and ethically acceptable manner. Also see their Agri-Biotechnology Section. (Posted September 2000.)
Exiqon A/S
Exiqon is a Danish biotech company focused on the development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases. In other fields Exiqon is a potential technology partner for licensees. Exiqon's IPR includes LNA (Locked Nucleic Acids) and a universal method for the covalent coupling of diagnostic molecules to solid supports. (Posted October 2000.)
Federal Bio-Technology Transfer Directory
The Federal Bio-Technology Transfer Directory is an integrated information resource designed for users in the biotechnology, pharmaceutical and healthcare industries. Besides being essential for access to technology transfer opportunities, the database is a unique source for competitive intelligence concerning federal (and corporate) research, development and commercialization activities. (Posted October 2000.)
Gemini Biotech
Gemini Biotech provides prompt, high quality, and cost-effective support for research and drug discovery. The company's technical staff and consultants are experts in synthetic chemistry and molecular biology. Gemini Biotech specializes in custom DNA probes/primers, modified oligonucleotides and DNA-RNA hybrids, full-length genes, gene sequencing, custom peptides and modifications, peptide conjugates, and peptide antibodies. (Posted October 2000.)
Genetics Forum
The Genetics Forum is an independent organisation in the UK concerned with the use of new genetic technologies and their public policy implications. It was founded by a group of scientists, lawyers and advocates from the animal welfare, environmental and consumer movements concerned about the long-term impact of rapid developments in the genetic sciences. (Posted September 2000.)
Genetics Institute
Genetics Institute is a leading biopharmaceutical company engaged in the discovery, development and commercialization of human pharmaceuticals through recombinant DNA and other technologies. The company has a diversified portfolio of licensed and proprietary pharmaceutical products at various stages of development, including treatments for anemia, hemophilia, cancer, bone damage, inflammatory conditions and immune system disorders. (Posted October 2000.)
Genzyme Transgenics Corporation
Genzyme Transgenics Corporation, a biotechnology company, is a leader in the production of therapeutic proteins in the milk of transgenic animals. Transgenic animals carry specific genetic material that allows them to produce human proteins in their milk. Unique molecular biology and production expertise has enabled Genzyme Transgenics to produce more than 60 therapeutic proteins, including monoclonal antibodies, plasma proteins and certain hard-to-express proteins in the milk of mice, rabbits, goats and cows. The company has developed substantial expertise and increasing focus on monoclonal antibodies for therapeutic use in chronic diseases such as rheumatoid arthritis, other autoimmune conditions and cancer. (Posted October 2000.)
Geron Corporation
Geron is a biopharmaceutical company that is focused on discovering, developing and commercializing therapeutic and diagnostic products for applications in oncology, drug discovery and regenerative medicine. Geron's product development programs are based upon three patented, independent and synergistic technologies: telomerase, human pluripotent stem cells, and nuclear transfer. (Posted October 2000.)
Greenpeace: Genetic Engineering
This site, which is operated by Greenpeace, advocates no genetic manipulation of nature. It focuses on (1) promoting natural foods and the segregation of genetically engineered foods with proper labels, (2) preventing genetically modified organisms from being released into the environment, (3) preventing any living organisms or their genes being subject to private property claims (i.e., no patents), and (4) promoting genetic engineering issues being addressed by international bodies, with international regulations based on the precautionary principle.  

Greenpeace USA, a part of the international organization dedicated to protecting the health of planet Earth, offers on-line media kits providing background information on various issues, including Greenpeace's concern that the FDA's safety standards regarding genetically engineered foods are insufficient and may be putting human health at risk. This media kit links to Greenpeace's report titled FDA Approved: Genetically Engineered Soy and Corn in Baby Food and Nutritional Supplements and to additional related information. (Posted September 2000.)

Igene Biotechnology
Igene Biotechnology focuses on the commercialization of value-added specialty biochemical products for the food, feed, flavor and agrichemical industries. Through the use of state-of-the-art fermentation technology, physical and chemical separation technology, and related chemical and biochemical engineering technologies, the company has developed proprietary processes to convert selected agricultural raw materials or feedstock into commercially useful and cost effective "environmentally friendly" natural alternatives to products now produced by chemical synthesis. (Posted October 2000.)
InfoBiotech Canada (IBC)
IBC is a partnership of government, private and academic sectors with the goal of providing enhanced access to information on Biotechnology in Canada and worldwide. (Posted September 2000.)
Information Systems for Biotechnology (ISB)
ISB provides information resources to support the environmentally responsible use of agricultural biotechnology products. Here you will find documents and searchable databases pertaining to the development, testing and regulatory review of genetically modified plants, animals and microorganisms within the U.S. and abroad. (Posted September 2000.)
Insect Biotech Canada Inc. (IBC)
Insect Biotech Canada Inc. (IBC) is a Canadian-based, non-profit biotechnology research and development consortium focused on the application of biotechnology to insects and their pathogens. IBC has brought together Canada's top researchers in insect physiology, biochemistry, insect virology and molecular biology in an integrated and coordinated organization. The network is focused on serving the needs of Canada and the international community in identifying and controlling insect pests using current techniques of biotechnology. (Posted September 2000.)
Institute of Biosciences and Bioengineering, Rice University
The Institute's mission is to promote cross-disciplinary research and education encompassing the biological, chemical, and engineering disciplines. The Institute represents a unique educational environment in which to prepare students to meet the complex scientific, technological, and ethical challenges they face as they head into the twenty-first century. (Posted September 2000.)

International Centre for Genetic Engineering and Biotechnology

The International Centre for Genetic Engineering and Biotechnology (ICGEB) was established in 1987 by the United Nations Industrial Development Organization (UNIDO) to promote the safe use of biotechnology world-wide and with special regard to the needs of the developing world. In 1995 it became a fully autonomous international organization composed of 41 member states. It has two main laboratories: one in Trieste, Italy, and one in New Delhi, India. It also hosts a network of 27 Affiliated Centres, which are national laboratories of member states. It sponsors both basic and applied research, including the production of novel malaria and hepatitis vaccines, the study of human pathogenic viruses, the study of human genetic diseases, and the genetic manipulation of plants. In 1995, ICGEB and UNIDO created BINAS (Biosafety Information Network and Advisory Service) to monitor global developments in regulatory issues in biotechnology. In 1998, the Centre added the ICGEB Biosafety WebPages, which are totally dedicated to biosafety and risk assessment for the environmental release of genetically modified organisms. Also in 1998, the Centre began publishing biosafety, a bibliography of scientific articles on the main topics of concern about the environmental release of genetically modified organisms. (Updated May 2000.)

InterSciences Inc.
InterSciences is a privately-owned and operated, scientific instrumentation and supplies marketing organization representing specialized principal manufacturers lines. InterScience's primary marketing focus is Biotechnology for academic and hospital research, industrial, government, private lab and Pharmaceutical segments of the Canadian market. (Posted October 2000.)
Iomai Corporation
Iomai is a biopharmaceutical company with products that greatly enhance human immune systems in the fight against disease using its Transcutaneous Immuno Modulation (TIM) technology for immunoprevention and immunotherapy. TIM works through the skin as a non-invasive booster to the body's own immune system and can be targeted against specific diseases. TIM products are administered easily and safely -- painlessly stimulating the immune system to prevent or treat disease through a skin patch, without needles or injections. The Company is focused on rapid commercialization of the TIM technology through strategic relationships with industry partners. The TIM project pipeline includes products for three target markets: infectious diseases, cancer therapies and autoimmune therapies. (Posted October 2000.)
Leinco Technologies 
Leinco Technologies is a global biosciences company with manufacturing facilities. The company is built on a diverse biotechnology platform and offers product development and contract manufacturing services under GLSP and cGMP for active biopharmaceutical intermediates. The company also offers an extensive line of antibodies, recombinant proteins and reagents for research in immunology, cell biology, and neuroscience.  (Posted October 2000.)
Link Technologies Ltd
Link Technologies Ltd, established in Glasgow in 1989, is a growing biotechnology company that now operates at the Strathclyde Business Park. The company, which has a strong reputation in the U.S. and European markets for manufacturing quality chemical reagents for the synthesis and modification of DNA and RNA, is now also developing innovative reagents for use in related areas of molecular biology, such as the structural study of proteins and the synthesis of oligonucleotide-peptide conjugates. In tandem with its expanding catalogue of products, the company offers a contract synthesis service for molecular biology reagents. (Posted October 2000; updated August 2002.)
Louisiana Alliance for Biotechnology (LAB)
LAB is dedicated to enhancing biotechnology research and business development in the State of Louisiana. The goals set for LAB in order to accomplish this mission are to facilitate: the development of an interactive consortium of university and private sector researchers in molecular biology and biotechnology; the transfer of scientific advances into the private sector; enhancement of the university academic environment and community quality of life through economic development associated with increased private sector research and development; development and funding of research to improve and expand Louisiana’s agriculture and industry; coordination of state, federal, academic and business sector efforts to improve economic conditions within the state through economic development in the biotechnology sector. (Posted September 2000.)
LumaCareTM Biotechnology
LumaCareTM is a scientific company developing instrumentation products in the field of biotechnology. The company has developed a specialized noncoherent light source for the field of photodynamic therapy (PDT) and for universal use with new Biotech pharmaceuticals (such as Photofrin). Photodynamic therapy is a safe, non-invasive treatment for numerous diseases, including psoriasis and other dermatological afflictions. (Posted October 2000.)
Lynx Therapeutics, Inc.
Lynx applies its genomics, genetics, and proteomics technologies to accelerate the pace, broaden the scale, enhance the quality, and lessen the cost of the discovery and development efforts of customers in the pharmaceutical and agricultural biotechnology industries. Lynx has developed, and continues to develop, unique, proprietary processes aimed at handling and analyzing, simultaneously, very large numbers of DNA molecules or fragments in complex biological samples. At the core of these processes is Lynx’s Megaclone™ technology. This is a micro-bead technology that allows both the simultaneous collection of millions of clones on as many micro-beads, and subsequent simultaneous manipulation or analyses of these clones. Applications include the physical extraction of genes (whether known or unknown) that are differentially expressed between samples (Megasort™ technology), the characterization of gene expression within a sample by Massively Parallel Signature Sequencing (MPSS®) technology, and a novel, highly efficient means for genotyping very large numbers of genetic markers or single nucleotide polymorphisms (SNPs), simultaneously, against large populations of genomes (Megatype™ technology). (Posted October 2000.)
Mendel Biotechnology
Mendel is a pioneer in the application of functional genomics to the study of plant genes. Mendel's business objective is to discover and characterize the function of important plant genes and to develop and commercialize high-margin products based on these discoveries. These products will benefit customers in agriculture, healthcare, specialty ingredient, and consumer product markets. (Posted October 2000.)
Metkinen Chemistry
Metkinen Chemistry provides unique reagents for DNA and RNA synthesis. They produce Truly Universal solid support for synthesis of DNA and RNA oligonucleotides and trimer (codon) phosphoramidites. In addition, a variety of purine nucleoside analogs and phosphoramidites are available. (Posted October 2013.)
Michigan Biotechnology Association (MBA)
The MBA, a not-for-profit membership association, was launched to increase the understanding of the benefits of biotechnology and to support the growth of bio-based businesses in Michigan. The development of infrastructure to assist in the growth of biotechnology businesses is the primary goal of MBA. MBA also disseminates information of interest to it's members. Its members include companies, universities, research institutes and individuals who are, or would like to become, involved in biotechnology.  (Posted September 2000.)
Micrologix Biotech Inc.
Micrologix Biotech is a public biopharmaceutical company focusing on the discovery, development and commercialization of innovative drugs to treat life-threatening diseases. Our drug candidates are based on the development of improved derivatives of naturally occurring peptide compounds found in the defense systems of virtually all life forms. These powerful proprietary compounds are remarkably effective at killing the multidrug-resistant microbes responsible for the most clinically important infectious diseases. (Posted October 2000.)

National Biotechnology Information Facility

The National Biotechnology Information Facility (NBIF) provides a single-point access to a vast store of widely distributed biotechnology data including approximately 7,000 links to biotechnology resources. The NBIF encourages information sharing between researchers in Academia, Industry, Government, and the Department of Defense, promotes biotechnology in Historically Black Colleges and Universities and Minority Institutions (HBCU/MIs), and provides training in biotechnology. The NBIF is also active in developing new sources and types of biotechnology databases. (Posted January 28, 2000.)

National Center for Biotechnology Information (NCBI)
NCBI, a national resource for molecular biology information, creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information, all for the better understanding of molecular processes affecting human health and disease. (Posted October 2000.)
Nature Biotechnology Directory
The Nature Biotechnology Directory is a global information resource listing over 9,000 organizations, product and service providers in the biotechnology industry. Entries display details about each organization, including organization name, address, telephone and fax number, e-mail and web addresses. (Posted October 2000.)
Neugenesis Corporation
Neugenesis Corporation is a biotechnology company focused on generating better biotherapeutics cost-effectively. To this end, Neugenesis has developed technology that has substantial value in discovering, improving, and producing complex proteins, especially heteromeric proteins. The company's work with the filamentous fungus Neurospora crassa has resulted in significant advances in two important areas of biotechnology research, recombinant protein production and combinatorial biology. (Posted October 2000.)
New Zealand Biotechnology Association
The Association was established to improve knowledge of biotechnology in New Zealand; to represent the interests of those concerned with biotechnology in New Zealand; to provide a forum for interaction among the disciplines involved in biotechnology; and to foster an environment conducive to the growth of biotechnology-based industries in New Zealand.  (Posted September 2000.)
North Carolina Biotechnology Center
The Center's mission is to provide long-term economic benefit to North Carolina through support of biotechnology research, development and commercialization statewide. It  works toward that mission by assisting business, education, and science. The Center is active at all points in the movement of biotechnology from ideas to marketable products. It  works with academic researchers, entrepreneurs and company scientists, educators, governmental policy-makers and all other parties involved in building a thriving biotechnology industry. (Posted September 2000.)
Northern Bioidentification Service Ltd. 
Northern Bioidentification Service Ltd. is a biotechnology company providing DNA analysis techniques to fish and wildlife conservation managers. The company works with animal conservation managers and researchers to protect and improve natural stocks of fish and wildlife. Through the use of high-quality DNA typing and population genetic analysis, the company aims to provide powerful and cost-effective tools used in conservation management. (Posted October 2000.)
NRC Biotechnology Research Institute
BRI is located in Montréal, Canada, and maintains advanced facilities to carry out collaborative research projects in molecular biology and biochemical engineering, including: radiocrystallography equipment, an ion spray mass spectrometer, NMR spectrometers, computer-assisted molecular design, confocal light scanning microscopy system, analytical chemistry laboratory (for the environmental sector), a 1,500 m² bioprocess facility with fermenters ranging in size from 3.5 L to 1,500 L, and 350 m² of clean rooms for separation and purification (class 10,000 and 100,000). BRI concentrates its resources on collaborative projects with Canadian industry, particularly companies working in the pharmaceutical and resource sectors. (Posted September 2000.)
NRC Plant Biotechnology Institute
The mission of the Plant Biotechnology Institute is to perform, assist and promote strategic research in plant biotechnology, to improve and diversify Canadian industry, and to strengthen Canada’s competitive position in the global economy by fostering an entrepreneurial culture. The Institute performs strategic research in key areas of plant biotechnology while maintaining a world-class research calibre; ensures industrial relevance of its research programs; nurtures innovation through efficient transfer of new biotechnologies and their products to commercialization; provides infrastructure and expertise; informs and transfers discoveries in plant biotechnology to all interested parties in Canada; and trains and develops highly qualified personnel in selected areas of plant biotechnology. (Posted September 2000.)
Onyvax Limited
Onyvax is an early-stage biotechnology company focused on the development of cancer therapies that employ the selectivity and power of the immune system to seek and destroy tumor cells. (Posted October 2000.)
Osmetech is dedicated to the rapid and inexpensive detection of micro-organisms such as infectious bacteria, fungi and moulds through the application of multi-sensor array technology. (Posted September 2000.)
Pew Initiative on Food and Biotechnology
Established to be an independent and objective source of credible information on agricultural biotechnology for the public, media and policymakers, the Pew Initiative on Food and Biotechnology is funded through a grant from The Pew Charitable Trusts to the University of Richmond. The Initiative advocates neither for, nor against, agricultural biotechnology but instead is committed to providing information and encouraging debate and dialogue so that consumers and policymakers can make their own informed decisions. (Posted October 2001.)
Phytera, Inc.
Phytera, Inc. is an international biotechnology company that applies the genetic and chemical diversity of natural species to the discovery of new pharmaceutical, agricultural and other products. Phytera has developed proprietary cell culture technologies for plant species (ExPAND®) and marine microbes (µMARINE®) that provide the Company with unique and greatly expanded access to the genetic and chemical diversity of each species. To date, the Company has assembled the largest library of plant cells in culture in the world and also has an extensive library of marine microbial cultures. The ExPAND® and µMARINE® technologies involve extensive manipulation of the cell cultures to simulate many different environments. This combinatorial biology approach turns on silent genes in the cultured cells and results in the expression of greatly expanded chemical diversity. Phytera captures the genes and expanded chemical diversity in its proprietary databases and libraries. (Posted October 2000.)
Princeton Separations, Inc. (PSI)
PSI is a privately-owned, manufacturing-based biotechnology company specializing in molecular separations. PSI manufactures various successful products including: CENTRI·SEPTM spin columns, used in DNA sequencing; PANAGEL® high-resolution electrophoresis systems, used in analysis of proteins in human body fluids; CENTRI·SPINTM  columns, used in the purification of a variety of biomolecules (DNA, proteins and carbohydrates) and PSI  CLONE Plasmid Prep kit for purification of plasmid DNA.  (Posted October 2000.)
Progen Industries Limited
Progen Industries Limited is an Australian biotechnology company specialising in the manufacture and supply of molecular biology reagents and kits. Involved in pharmaceutical research and development, Progen recently commenced its second Phase I clinical trial with its lead compound (PI-88) for treatment of solid tumors. Progen is also involved in the development of a number of other potential biopharmaceuticals. (Posted October 2000.)
Recombinant Capital (ReCap)
The purpose of the ReCap website is to provide a resource to biotechnology executives who are involved with financing, business development, licensing and other strategic planning essential to the development and commercialization of biotechnology, pharmaceuticals, diagnostics and medical devices. (Posted October 2000.)
Reliable Biopharmaceutical Corporation
Reliable Biopharmaceutical Corporation is a manufacturer of active pharmaceutical ingredients, nucleic acids, biochemicals, and enzymes for the pharmaceutical and biotechnology industries. The company isolates deoxynucleosides and deoxynucleotides from Salmon DNA. The company's nucleotides and nucleosides are of the highest purity available. They also synthesize DMT protected 2'O methyl ribonucleosides and deoxynucleosides. After these protected deoxy and ribo nucleosides are converted to phosphoramidite derivatives, they can be incorporated into the new antisense therapeutic and diagnostic compounds.  (Posted October 2000.)
Reticula Bio
Reticula Bio is a research and development consortium that specializes in advanced technology and biopharmaceutical research and development. The company's two divisions reflect its broad research interests. The biosciences division investigates and develops novel pharmaceutical, biotechnology and agricultural products and the advanced technologies division specializes in immersive technology, robotics and computing applications. (Posted October 2000.)
Q-One Biotech
Q-One Biotech is a world-renowned authority in providing specialist safety testing and process validation services, cGMP contract manufacturing of cell banks, vaccines and gene therapy products to the biopharmaceutical industry. Q-One operates in full compliance with GMP and GLP standards. (Posted October 2000.)
Quebec Bio-Industries Association
The Quebec Bio-Industries Association, which counts close to 200 innovative companies as members, is committed to supporting the growth and vitality of Quebec’s biotechnology companies. The QBA's member companies are active in research and manufacturing of therapeutic and diagnostic products, vaccines and biological products of human and animal health; in research and primary production in the areas of agriculture, aquaculture, secondary processing and beverages; and in research and production in the waste treatment, biomass processing, environmental rehabilitation, mining and peat bog sectors. (Posted September 2000.)
Quebec Biotechnology Innovation Centre (QBIC)
QBIC is the first business incubator specializing in biotechnology to emerge in Québec. This non-profit organization offers researcher-entrepreneurs in Québec and elsewhere, an environment conducive to their research and development activities, while promoting the acquisition and transfer of management skills. The goal of the QBIC is to promote the development of young innovative companies working in the field of biotechnology applied to the health, environment, agri-food and forestry sectors. To do this, the QBIC makes specialized equipment infrastructures available to these companies and offers them business services and counseling in line with their needs. By supporting the start-up of companies in this new economic sector, the QBIC and its partners are contributing to job creation in Québec and the emergence of a generation of entrepreneurs in the biotechnology sector. (Posted September 2000.)
Seikagaku Corporation
Seikagaku Corporation has evolved into a major contributor in the biotech industry specializing in pharmaceutical products such as ARTZ®, research biological and diagnostics such as Endospecy®, as well as pursuing R&D efforts in developing technologies based on Glycoconjugates. (Posted October 2000.)
Senetek PLC
Senetek PLC is a science-driven biotechnology company that develops, manufactures and markets proprietary solutions for aging-related healthcare problems. Senetek business divisions include three separate, distinct and significant opportunities in biopharmaceuticals, autoinjectable drug delivery systems, and cosmeceuticals. (Posted October 2000.)
Sunnyday Environmental & Bio-Tech Services Ltd.
While Sunnyday has the staff, expertise and experience to handle a wide variety of projects, their specialty is the design and construction of complete utility systems for pharmaceutical research labs and cGMP pilot plant facilities which demands specific knowledge with regard to cGMP and FDA requirements. The ultimate goal is not only high performance, but also validation of utility systems. All the necessary equipment, instrumentation and control, material and labor are supplied to meet the needs of the company's projects. For pure steam/WFI systems the company performs the orbital stainless steel welding using computer controlled automatic equipment to secure consistent quality. (Posted October 2000.)
Techniclone Corporation
Techniclone Corporation is a biotechnology company focused on the research, development and commercialization of novel cancer therapeutics in two principal areas: 1) direct tumor targeting agents for the treatment of refractory malignant lymphomas and 2) collateral indirect targeting agents for the treatment of solid tumors.  (Posted October 2000.)

Technology to Feed the World
U.S. National Academy of Sciences (NAS) Web Extra

An international working group of seven science academies--Royal Society of London, the U.S. National Academy of Sciences, the Brazilian Academy of Sciences, the Chinese Academy of Sciences, the Indian National Science Academy, the Mexican Academy of Sciences, and the Third World Academy of Sciences--issued a white paper on July 11, 2000, titled Transgenic Plants and World Agriculture, which details ways agricultural biotechnology can help alleviate hunger and poverty in the Third World. This NAS web extra links to the paper and to additional information about biotechnology. (Posted July 2000.)

Toronto Biotechnology Initiative (TBI)
The TBI is a non-profit organization committed to promoting the growth of biotechnology in Toronto and the surrounding region. While biopharmaceuticals and diagnostics are core strengths of this community, it also has broad research capability and growing commercial activity in agri-food biotechnology as well as the emerging resource and environmental biotech industries. (Posted September 2000.)
Transgenomic, Inc.
Transgenomic, Inc. is a global company with a core biotechnology business that includes principal technologies for DNA/RNA and analysis and purification. This diverse technology base enables world-class research with technology and instrumentation that allows scientists to get the answers they seek faster and with greater confidence. Principal application areas include: genetic mutation screening and detection, plus new paths in microbial, pharmaceutical, biotechnology, forensic, plant and animal research. (Posted October 2000.)
University of Wisconsin Biotechnology Center 
The University of Wisconsin Biotechnology Center was established to coordinate the vigorous development of biotechnology on the UW-Madison campus. As the UWBC grew, a service facilities was established to provide excellent shared resources for the UW-Madison, state and national biotechnology research communities. Outreach functions were developed, including technology transfer, biotechnology education for the public, and the gathering and dissemination of information through the Center's newsletter, Wisconsin BioIssues, and through the Internet. Multidisciplinary applied research programs were started (including biopulping, bioremediation, and the production of industrial enzyme in transgenic alfalfa) that were supported by federal and state grants and industrial consortia. (Posted October 2000.)
Vical Incorporated
Vical develops biopharmaceutical products based on patented naked DNA gene transfer technologies for the prevention and treatment of life-threatening diseases. The company currently focuses its development on innovative cancer therapies designed to induce an immune response against cancer cells without causing serious side effects.  (Posted October 2000.)
Virginia BioTechnology Research Park
The Virginia BioTechnology Research Park is a technology center dedicated to fostering development of Virginia's biosciences industry through technology transfer, new business formation, expansion of existing businesses, and business attraction. (Posted October 2000.)
World Wide Web Virtual Library: Biotechnology
This directory contains URLs of companies, research institutes, universities, sources of information and other directories specific to biotechnology, pharmaceutical development and related fields. It places emphasis on product development and the delivery of products and services. (Posted October 2000.)
Xencor™ is a biotechnology company that is commercializing Protein Design Automation™ (PDA), a proprietary research platform for protein design. PDA builds on recent groundbreaking advances in computer capabilities and computational chemistry methods to design protein and peptide variants, as well as completely unique protein sequences. PDA produces novel proteins that preserve target functions while modifying selected chemical and biological properties. PDA can rapidly examine vastly more protein sequences than is possible for methods based on genetic screening and selection, resulting in a higher success rate and access to a wider range of novel protein properties.  (Posted October 2000.)
ZymeTx, Inc.
ZymeTx is an emerging biotechnology company engaged in the discovery, development and commercialization of unique products for the diagnosis and treatment of viral diseases. The scientific foundation for its business is based upon the role of enzymes in the process of viral infection. ViraZyme, its core technology, exploits the subtle structural differences and characteristics of enzymes to create viral diagnostic and therapeutic products. (Posted October 2000.)

Designed and maintained by Tec-Com Inc.

Copyright © 2013 by Tec-Com Inc.